TEVA Teva Pharmaceutical Industries Limited
Healthcare$34.61+1.58%ClosedMarket Cap: $40.30B
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
0
Dispositions
4
Buy/Sell Ratio
0.00
Net Shares
-206,117
Shares Acquired
0
Shares Disposed
206,117
Total Bought ($)
$0.00
Total Sold ($)
$4.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon May 18 | Lippman Evan | officer: EVP, Business Development | Sell | 35,912 | $35.58 | 44,191 |
| Mon May 18 | Lippman Evan | officer: EVP, Business Development | Sell | 5,746 | $35.58 | 6,095 |
| Mon May 18 | Lippman Evan | officer: EVP, Business Development | Sell | 74,008 | $0.00 | 80,103 |
| Mon May 18 | Lippman Evan | officer: EVP, Business Development | Sell | 11,841 | $0.00 | 35,524 |
| Mon May 18 | Kalif Eliyahu Sharon | officer: EVP, Chief Financial Officer | Sell | 153,251 | $35.61 | 172,184 |
| Thu May 07 | Weiss Amir | officer: Chief Accounting Officer | Sell | 10,679 | $36.00 | 20,016 |
| Thu May 07 | Daniell Richard | officer: EVP, Europe Commercial | Sell | 30,000 | $35.40 | 55,755 |
| Mon May 04 | Sabag Mark | officer: See "Remarks" | Sell | 144,180 | $34.99 | 80,760 |
| Mon May 04 | Fox Christine | officer: EVP, U.S. Commercial | Sell | 21,258 | $35.31 | 63,647 |
| Thu Mar 19 | Sabag Mark | officer: See "Remarks" | Sell | 62,102 | $30.14 | 224,940 |
| Mon Mar 09 | Weiss Amir | officer: Chief Accounting Officer | Sell | 3,537 | $0.00 | 30,695 |
| Mon Mar 09 | Sabag Mark | officer: See "Remarks" | Sell | 15,723 | $0.00 | 287,042 |
| Mon Mar 09 | Kalif Eliyahu Sharon | officer: EVP, Chief Financial Officer | Sell | 19,916 | $0.00 | 325,435 |
| Mon Mar 09 | Francis Richard D | officer: President and CEO | Sell | 20,025 | $31.67 | 1,170,639 |
| Mon Mar 09 | Francis Richard D | officer: President and CEO | Sell | 42,452 | $0.00 | 1,190,664 |